Historical record - last NADAC effective date: 4/1/2022
Product Information
MUCINEX FAST-MAX CHEST-CONGEST is a brand product labeled by RB Health (US) LLC, priced at $0.0606 per ML under NDC 63824053766. Its NADAC has been published 19 times since Feb 23, 2022.
The High Outlier badge above means this manufacturer's average price in the Guaifenesin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
400 mg/20mL
Manufacturer
RB Health (US) LLCNDC
63824053766
Classification
Brand
Dosage Form
SOLUTION
Route
ORAL
Effective Date
4/1/2022
Active Ingredients
GUAIFENESINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
6/1/2020
Pharmacological Classes
Price Statistics
The NADAC for MUCINEX FAST-MAX CHEST-CONGEST has been published 19 times since Feb 23, 2022, and over the history we have for it it has risen 16.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0606 per ML |
|---|---|
| All-time high | $0.0606 (Jun 29, 2022) |
| All-time low | $0.0520 (Feb 23, 2022) |
| Median price | $0.0606 |
| Average price | $0.0579 |
| Largest weekly change | +16.7% (Apr 6, 2022) |
| Weeks tracked | 19 |
| Tracking since | Feb 23, 2022 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+16.7%
Last surveyed Jun 29, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Guaifenesin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
RB Health (US) LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Guaifenesin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MUCINEX FAST-MAX CHEST-CONGEST?
The current National Average Drug Acquisition Cost (NADAC) for MUCINEX FAST-MAX CHEST-CONGEST, manufactured by RB Health (US) LLC, is $0.0606 per ML (NDC 63824053766), effective Jun 29, 2022.
How has the price of MUCINEX FAST-MAX CHEST-CONGEST changed over time?
Over the history we have for it, the NADAC for MUCINEX FAST-MAX CHEST-CONGEST has risen 16.7%. It has been tracked across 19 weekly CMS publications since Feb 23, 2022.
What are the highest and lowest recorded NADAC prices for MUCINEX FAST-MAX CHEST-CONGEST?
Since Feb 23, 2022, the NADAC for MUCINEX FAST-MAX CHEST-CONGEST has ranged from a low of $0.0520 (Feb 23, 2022) to a high of $0.0606 (Jun 29, 2022), with a median of $0.0606 per ML.
Are there cheaper alternatives to MUCINEX FAST-MAX CHEST-CONGEST?
No other NADAC-published product currently shares the active ingredient and strength of MUCINEX FAST-MAX CHEST-CONGEST in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MUCINEX FAST-MAX CHEST-CONGEST?
MUCINEX FAST-MAX CHEST-CONGEST (NDC 63824053766) is labeled by RB Health (US) LLC, and CMS classifies it as a brand product.